Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammationand immunologically-mediated diseases

Details for Australian Patent Application No. 2004222563 (hide)

Owner Novartis AG

Inventors Moore, Henrietta

Agent Davies Collison Cave

Pub. Number AU-B-2004222563

PCT Pub. Number WO2004/082681

Priority 0306070.4 17.03.03 GB; 0306868.1 25.03.03 GB; 0319226.7 15.08.03 GB

Filing date 16 March 2004

Wipo publication date 30 September 2004

Acceptance publication date 2 November 2006

International Classifications

A61K 31/436 (2006.01)

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/082681 Priority application(s): WO2004/082681

2 November 2006 Application Accepted

  Published as AU-B-2004222563

1 March 2007 Standard Patent Sealed

15 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004222587-Dose dial and drive mechanism suitable for use in drug delivery devices

2004222562-Use of acylcyclohexanedione derivatives for improving the tolerance of plants to cold and/or frost